Efficacy and Safety of Dupilumab With Concomitant Topical Corticosteroids in Children 6 to 11 Years Old With Severe Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Dupilumab With Concomitant Topical Corticosteroids in Children 6 to 11 Years Old With Severe Atopic Dermatitis: A Randomized, Double-Blinded, Placebo-Controlled Phase 3 Trial
J Am Acad Dermatol 2020 Jun 20;[EPub Ahead of Print], AS Paller, EC Siegfried, D Thaçi, A Wollenberg, MJ Cork, PD Arkwright, M Gooderham, LA Beck, M Boguniewicz, L Sher, J Weisman, JT O'Malley, N Patel, M Hardin, NMH Graham, M Ruddy, X Sun, JD Davis, MA Kamal, FA Khokhar, DM Weinreich, GD Yancopoulos, B Beazley, A Bansal, B ShumelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.